Sensitization of human erythroleukemia K562 cells resistant to methotrexate by inhibiting IMPDH

Medical Science Monitor

Volumn 11, Issue 1, 2005, Pages

  Peñuelas, Silvia ^a   Noé, Véronique ^a   Morales, Raúl ^a   Ciudad, Carlos J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

IMPDH2; K562; Methotrexate; Resistance

Indexed keywords

BENZAMIDE DERIVATIVE; BENZAMIDE RIBOSIDE; COMPLEMENTARY DNA; INOSINATE DEHYDROGENASE; INOSINATE DEHYDROGENASE 2; MESSENGER RNA; METHOTREXATE; MYCOPHENOLIC ACID; TIAZOFURIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ERYTHROLEUKEMIA CELL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; IMP DEHYDROGENASE; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; METHOTREXATE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 12244277408     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Chu E, Grem JL, Johnston PG, Allegra CJ: New concepts for the development and use of antifolates. Stem Cells, 1996; 14: 41-46
2. Huennekens FM: The methotrexate story: a paradigm for development of cancer chemotherapeutic agents. Adv Enzyme Regul, 1994; 34: 397-419
3. Goldman ID, Matherly LH: The cellular pharmacology of methotrexate. Pharmacol Ther, 1985; 28: 77-102
4. Wagner C: Symposium on the subcellular compartmentation of folate metabolism. J Nutr, 1996; 126: 1228S-34S
5. Alt FW, Kellems RE, Bertino JR, Schimke RT: Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J Biol Chem, 1978; 253: 1357-70
6. Dicker AP, Volkenandt M, Schweitzer BI et al: Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate-resistant Chinese hamster ovary cell line Pro-3 MtxRIII. J Biol Chem, 1990; 265: 8317-21
7. Yu M, Melera PW: Allelic variation in the dihydrofolate reductase gene at amino acid position 95 contributes to antifolate resistance in Chinese hamster cells. Cancer Res, 1993; 53: 6031-35
8. Srimatkandada S, Schweitzer BI, Moroson BA et al: Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug. J Biol Chem, 1989; 264: 3524-28
9. Dixon KH, Lanpher BC, Chiu J et al: A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J Biol Chem, 1994; 269: 17-20
10. Jansen G, Mauritz R, Drori S et al: A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J Biol Chem, 1998; 273: 30189-98
11. Roy K, Tolner B, Chiao JH, Sirotnak FM: A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells. J Biol Chem, 1998; 273: 2526-31
12. Zhao R, Sharina IG, Goldman ID: Pattern of mutations that results in loss of reduced folate carrier function under antifolate selective pressure augmented by chemical mutagenesis. Mol Pharmacol, 1999; 56: 68-76
13. Sun J, He ZG, Cheng G et al: Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med Sci Monit, 2004; 10(1): RA5-RA14
14. Roy K, Egan MG, Sirlin S, Sirotnak FM: Posttranscriptionally mediated decreases in folylpolyglutamate synthetase gene expression in some folate analogue-resistant variants of the L1210 cell. Evidence for an altered cognate mRNA in the variants affecting the rate of de novo synthesis of the enzyme. J Biol Chem, 1997; 272: 6903-8
15. Rhee MS, Wang Y, Nair MG, Galivan J: Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity. Cancer Res, 1993; 53: 2227-30
16. Curt GA, Cowan KH, Chabner BA: Gene amplification in drug resistance: of mice and men. J Clin Oncol, 1984; 2: 62-64
17. Carman MD, Schornagel JH, Rivest RS et al: Resistance to methotrexate due to gene amplification in a patient with acute leukemia. J Clin Oncol, 1984; 2: 16-20
18. Srimatkandada S, Dube SK, Carmen M, Bertino JR: Coamplification of 3-hydroxy-3-methylglutaryl coenzyme A reductase genes in methotrexate-resistant human leukemia cell lines. Oncol Res, 2000; 12: 11-15
19. Koizumi S: Impairment of methotrexate (MTX)-polyglutamate formation of MTX-resistant K562 cell lines. Jpn J Cancer Res, 1988; 79: 1230-37
20. Bednar M: DNA microarray technology and application. Med Sci Monit, 2000; 6: 796-800
21. Rihn BH, Vidal S, Nemurat C et al: From transcriptomics to bibliomics. Med Sci Monit, 2003; 9(8): MT89-MT95
22. Weber G: Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. Cancer Res, 1983; 43: 3466-92
23. Jackson RC, Weber G, Morris HP: IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature, 1975; 256: 331-33
24. Knight RD, Mangum J, Lucas DL et al: Inosine monophosphate dehydrogenase and myeloid cell maturation. Blood, 1987; 69: 634-39
25. Collart FR, Chubb CB, Mirkin BL, Huberman E: Increased inosine-5′-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines. Cancer Res, 1992; 52: 5826-28
26. Huberman E, Glesne D, Collart F: Regulation and role of inosine-5′-monophosphate dehydrogenase in cell replication, malignant transformation, and differentiation. Adv Exp Med Biol, 1994; 370: 741-46
27. Nagai M, Natsumeda Y, Konno Y et al: Selective up-regulation of type II inosine 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res, 1991; 51: 3886-90
28. Oz HS, Hughes WT, Thomas EK, McClain CJ: Effects of immunomodulators on acute Trypanosoma Cruzi infection in mice. Med Sci Monit, 2002; 8: BR208-BR211
29. Balzarini J, Karlsson A, Wang L et al: Eicar (5-ethynyl-1-beta-D- ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis. J Biol Chem, 1993; 268: 24591-58
30. Hall A: A biochemical function for ras-at last. Science, 1994; 264: 1413-14
31. Chu E, Takechi T, Jones KL et al: Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro. Mol Cell Biol, 1995; 15: 179-85
32. Satav JG, Modak MJ, Studzinski GP: Photoaffinity labeling of human c-myc protein with deoxythymidine triphosphate. Lab Invest, 1990; 63: 551-56